Tuesday, September 15, 2026
29.6 C
Bengaluru

India’s Hospital Acquisitions Surge: RCML’s Pratiksha Deal Signals Expansion and Industry Trends

The healthcare sector in India has entered a dynamic phase of transformation, marked by record-breaking mergers and acquisitions (M&A) that are redefining national hospital networks, with increasing emphasis on pediatric, specialty, and regional expansion.

Spotlight: Rainbow Children’s Medicare Limited (RCML) Acquires Pratiksha Hospital

In August 2025, Hyderabad-based Rainbow Children’s Medicare Limited (RCML) announced its acquisition of a 76% controlling stake in Guwahati’s Pratiksha Hospital, valued at ₹171 crore. This all-cash transaction was fully funded via RCML’s reserves and internal accruals, expanding their network into Assam and the broader Northeast, and adding 150 beds to a national portfolio totaling 2,185 beds across 21 hospitals in eight cities[1][2][3][4][5].

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Topics

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...
spot_img

Related Articles

spot_imgspot_img